ANDROPHARM M1 ALPHA — Class I drug recall D-1143-2017
Terminated recall by Andropharm, LLC, reported 2017-09-20, distributed in FL. Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
| Recall number | D-1143-2017 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Andropharm, LLC, Boca Raton, FL, United States |
| Recall initiated | 2017-06-06 |
| Classified | 2017-09-12 |
| Reported by FDA | 2017-09-20 |
| Terminated | 2020-06-02 |
| Distributed | FL |
| Quantity | 1,250 bottles |
| Reason classes | labeling, unapproved product |
| UPC / GTIN / UDI-DI | 00642125502924 |
Product
ANDROPHARM M1 ALPHA (Methyl-1-Etiocholenolol-Epietiocholanollone 20 mg) capsule, packaged in 60-count bottle, Amazon.com, UPC 6 42125 50292 4
Reason for recall
Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1143-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.